The leading hypothesis in the field is that high MITF expression (MITFhigh) is associated with a differentiated and proliferative phenotype, whereas low MITF expression (MITFlow), is associated with a dedifferentiated, invasive, apoptosis-resistant, and melanoma-initiating cell phenotype [21]. The gene discussed is MITF; the disease is melanoma.